001     296166
005     20250302015345.0
024 7 _ |a 10.1016/j.jhin.2024.12.010
|2 doi
024 7 _ |a pmid:39788455
|2 pmid
024 7 _ |a 0195-6701
|2 ISSN
024 7 _ |a 1532-2939
|2 ISSN
024 7 _ |a altmetric:173108402
|2 altmetric
037 _ _ |a DKFZ-2025-00093
041 _ _ |a English
082 _ _ |a 610
100 1 _ |a Göpel, Siri
|b 0
245 _ _ |a Drivers of extended spectrum β-lactamase (ESBL)-producing Enterobacterales colonization among residents of long-term health care facilities: a European multicentric prospective cohort study.
260 _ _ |a Kidlington [u.a.]
|c 2025
|b Elsevier
336 7 _ |a article
|2 DRIVER
336 7 _ |a Output Types/Journal article
|2 DataCite
336 7 _ |a Journal Article
|b journal
|m journal
|0 PUB:(DE-HGF)16
|s 1740398157_16371
|2 PUB:(DE-HGF)
336 7 _ |a ARTICLE
|2 BibTeX
336 7 _ |a JOURNAL_ARTICLE
|2 ORCID
336 7 _ |a Journal Article
|0 0
|2 EndNote
500 _ _ |a 2025 Jan 7:157:67-74
520 _ _ |a ESBL-producing Enterobacterales (ESBL-PE) are highly prevalent in long-term healthcare (LTCF) settings. In order to estimate the acquisition rate of ESBL-producing Escherichia coli and Klebsiella pneumoniae in LTCF settings and identify clinical and environmental risk factors, a multicentric, prospective cohort study was conducted in six LTCFs in Germany, France, Spain and the Netherlands.Longitudinal screening of residents was performed over 32 weeks, collecting epidemiological and clinical data and environmental samples. The primary outcome was rate of new acquisition of ESBL-PE among LTCF residents. Molecular epidemiology was studied using whole genome sequencing and risk factor analyses using logistic and Poisson regression models.299 residents provided 1958 samples during follow-up. Prevalence of ESBL-PE colonization at baseline was 16.4%, incidence rate of acquisition was 0.79 per 1000 resident-days, both with high variability among centres. Age ≥80 years, vascular disease, and antibiotic consumption within one year were risk factors for baseline colonization. Lack of hand sanitizers and low nurse to resident ratio were associated with colonization. Presence of medical devices was associated with risk of acquisition. Vascular disease, hemiplegia, antibiotic consumption, and non-availability of private bathrooms were associated with multiple ST carriage. Prevalence of ESBL-PE among environmental samples was 2%, exclusively in centres with high prevalence among residents. Genetic analysis showed a high prevalence of ST10 E. coli and ST405 K. pneumoniae at two study sites.Infection prevention including availability of hand sanitizers, the number of nurses per resident, and antimicrobial stewardship interventions constitute important measures to control ESBL-PE in LTCFs. Genome-based surveillance could guide targeted interventions.
536 _ _ |a 313 - Krebsrisikofaktoren und Prävention (POF4-313)
|0 G:(DE-HGF)POF4-313
|c POF4-313
|f POF IV
|x 0
588 _ _ |a Dataset connected to CrossRef, PubMed, , Journals: inrepo02.dkfz.de
650 _ 7 |a ESBL producing Enterobacterales
|2 Other
650 _ 7 |a acquisition
|2 Other
650 _ 7 |a colonization
|2 Other
650 _ 7 |a long-term care facility
|2 Other
650 _ 7 |a molecular epidemiology
|2 Other
700 1 _ |a Guther, Julia
|b 1
700 1 _ |a Gladstone, Beryl Primrose
|b 2
700 1 _ |a Conzelmann, Nadine
|b 3
700 1 _ |a Bunk, Stefanie
|b 4
700 1 _ |a Terzer, Tobias
|0 P:(DE-He78)9c4af0f5ceb3a2072b3736274eadf20e
|b 5
700 1 _ |a Verschuuren, Tess D
|b 6
700 1 _ |a Martak, Daniel
|b 7
700 1 _ |a Salamanca, Elena
|b 8
700 1 _ |a Autenrieth, Ingo B
|b 9
700 1 _ |a group, MODERN WP1 study
|b 10
|e Collaboration Author
700 1 _ |a Peter, Silke
|b 11
700 1 _ |a Kluytmans, Jan A J W
|b 12
700 1 _ |a Hocquet, Didier
|b 13
700 1 _ |a Rodriguez-Baño, Jesus
|b 14
700 1 _ |a Tacconelli, Evelina
|b 15
700 1 _ |a Eisenbeis, Simone
|b 16
|e Contributor
700 1 _ |a Hölzl, Florian
|b 17
|e Contributor
700 1 _ |a Pascual, Alvaro
|b 18
|e Contributor
700 1 _ |a Medina, Rocío
|b 19
|e Contributor
700 1 _ |a Fluit, Ad
|b 20
|e Contributor
773 _ _ |a 10.1016/j.jhin.2024.12.010
|g p. S0195670125000015
|0 PERI:(DE-600)2002429-0
|p 67-74
|t The journal of hospital infection
|v 157
|y 2025
|x 0195-6701
909 C O |p VDB
|o oai:inrepo02.dkfz.de:296166
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 5
|6 P:(DE-He78)9c4af0f5ceb3a2072b3736274eadf20e
913 1 _ |a DE-HGF
|b Gesundheit
|l Krebsforschung
|1 G:(DE-HGF)POF4-310
|0 G:(DE-HGF)POF4-313
|3 G:(DE-HGF)POF4
|2 G:(DE-HGF)POF4-300
|4 G:(DE-HGF)POF
|v Krebsrisikofaktoren und Prävention
|x 0
914 1 _ |y 2025
915 _ _ |a Nationallizenz
|0 StatID:(DE-HGF)0420
|2 StatID
|d 2023-10-22
|w ger
915 _ _ |a JCR
|0 StatID:(DE-HGF)0100
|2 StatID
|b J HOSP INFECT : 2022
|d 2023-10-22
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0200
|2 StatID
|b SCOPUS
|d 2023-10-22
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0300
|2 StatID
|b Medline
|d 2023-10-22
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0199
|2 StatID
|b Clarivate Analytics Master Journal List
|d 2023-10-22
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1050
|2 StatID
|b BIOSIS Previews
|d 2023-10-22
915 _ _ |a WoS
|0 StatID:(DE-HGF)0113
|2 StatID
|b Science Citation Index Expanded
|d 2023-10-22
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0150
|2 StatID
|b Web of Science Core Collection
|d 2023-10-22
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1190
|2 StatID
|b Biological Abstracts
|d 2023-10-22
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0160
|2 StatID
|b Essential Science Indicators
|d 2023-10-22
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1110
|2 StatID
|b Current Contents - Clinical Medicine
|d 2023-10-22
915 _ _ |a IF >= 5
|0 StatID:(DE-HGF)9905
|2 StatID
|b J HOSP INFECT : 2022
|d 2023-10-22
920 1 _ |0 I:(DE-He78)C060-20160331
|k C060
|l C060 Biostatistik
|x 0
980 _ _ |a journal
980 _ _ |a VDB
980 _ _ |a I:(DE-He78)C060-20160331
980 _ _ |a UNRESTRICTED


LibraryCollectionCLSMajorCLSMinorLanguageAuthor
Marc 21